Latest Exploration Partnerships News

Prescient Therapeutics boosted enrolment in its PTX-100 Phase 2a trial to 28 patients and appointed Dr Rosalind Wilson as Chief Medical Officer, strengthening its clinical leadership as it advances targeted cancer therapies.

RareX Limited’s latest metallurgical program at Cummins Range delivers a breakthrough 9.5x upgrade in rare earth concentrate grade and confirms a viable gallium by-product extraction pathway, setting the stage for integrated multi-element processing.

Ingenia Communities is in discussions with Peet Limited and potential capital partners to extend its land lease portfolio beyond its current five-year plan, aiming to boost scale and financial flexibility.

Island Pharmaceuticals is progressing its broad-spectrum antiviral Galidesivir amid a severe Ebola outbreak, securing government approvals in Uganda and outlining a dual clinical and regulatory development pathway targeting multiple deadly filoviruses.

CZR Resources has reported promising assay results from its 2026 drilling and sampling campaigns across its Pilbara projects, highlighting significant copper-gold mineralisation at Croydon and strong iron ore potential at Yarraloola.

Chimeric Therapeutics has appointed Hawkesbury Partners to lead a strategic review aimed at exploring options to enhance shareholder value, reflecting concerns that its market cap undervalues its clinical assets and infrastructure.

Racura Oncology has raised $34.3 million through shareholder-backed initiatives, securing funding for its lead asset RC220’s clinical trials in AML, EGFRm lung cancer, and cardioprotection in solid tumour patients.

Tiger Gold has finalised its option to acquire LCL Resources’ Colombian gold assets with a $4.5 million payment, bringing total cash consideration to $7.5 million and strengthening LCL’s balance sheet ahead of a formal transfer on 11 June 2026.

Burley Minerals has reignited interest in its Chubb Lithium Project in Quebec following a lithium price uptick and promising drilling results revealing both spodumene and rare pollucite mineralisation. The company is weighing strategic options including further exploration, joint ventures, or sale.

ION Video has entered substantive early-stage discussions with Meta and Alphabet, exploring potential applications of its patented video virtualization technology. These talks are part of a broader engagement with major global tech players, though no formal deals have yet been struck.

Racura Oncology has secured governance approval to launch its Phase 1 HARNESS-1 trial, testing RC220 alongside osimertinib in EGFR-mutated non-small cell lung cancer patients. This milestone sets the stage for a potentially pivotal new approach to overcoming resistance in lung cancer treatment.

H3 Energy has appointed LAB Energy Advisors to spearhead farm-in talks for its Alinya project, a vast and underexplored oil and gas prospect in South Australia’s Officer Basin. The move aims to accelerate partner engagement ahead of drilling a potentially game-changing well.